Get Roswell Park Comprehensive Cancer Center essential facts below. View Videos or join the Roswell Park Comprehensive Cancer Center discussion. Add Roswell Park Comprehensive Cancer Center to your PopFlock.com topic list for future reference or share this resource on social media.
Roswell Park Comprehensive Cancer Center (founded 1898) is a cancer research and treatment center and a New York State public-benefit corporation located in Buffalo, New York and founded by Roswell Park. Candace S. Johnson is President & Chief Executive Officer of Roswell Park Comprehensive Cancer Center. In 2018, Roswell Park ranked #30 on U.S. News & World Report's list of the best cancer hospitals in the country. Roswell Park was the first dedicated medical facility for cancer treatment and research in the United States, and is the only upstate New York facility to hold the National Cancer Institute designation of "comprehensive cancer center." Roswell Park Comprehensive Cancer Center, which conducts clinical research on cancer as well as developing new drugs, provides advanced treatment for all forms of adult and pediatric cancer and serves as a member of the National Comprehensive Cancer Network.
The Roswell Park campus, spread out in 15 separate buildings of approximately two million square feet, occupies 28 acres (11 ha) on the 100-acre (40 ha) Buffalo Niagara Medical Campus (BNMC) in downtown Buffalo, and includes 1,500,000 square feet (140,000 m2) of space equally distributed between clinical programs and research/education functions. A separate hospital building, completed in 1998, houses a diagnostic and treatment center. The campus also includes a medical research complex as well as research and education focused space.
The Roswell Park Cancer Institute Corporation, which is the name of the New York public benefit corporation that operates the center, is guided by a 14-member board of directors (which has its own staff). The management team is headed by President and CEO Candace S. Johnson, PhD, who reports to the board. In 2017, it had operating expenses of $722.45 million, an outstanding debt of $189.67 million, and a staffing level of 2,919 people.
In 1898, Roswell Park Comprehensive Cancer Center was established by Roswell Park, who was a professor of surgery at the University of Buffalo School of Medicine. Park said that "Only through a deliberate well-planned, combined attack from various directions by means fitted for such work could real advances be made and further the relationship of laboratory work, clinical study and education must be closely associated."
Research started in three rooms in the University of Buffalo School of Medicine but not long thereafter, it outgrew the rooms. Seeing the importance of dedicated cancer research, select Buffalo citizens donated funds to purchase land and construct a new building. The largest contributor was Mrs. William Gratwick (wife of William H. Gratwick, the founder of Gratwick, Smith & Fryer Lumber Co.), who donated $25,000. The Gratwick Research Laboratory of the University of Buffalo was constructed in 1901 and was located at High and Elm streets.
Park wrote books, gave lectures, and was the administrator at the cancer research center. In 1904, Park stepped down and Harvey R. Gaylord took over as the Center's second director. Park remained as the chairman of the board of trustees.
Centers of Research
Roswell Park's centers include the Breast Service; Chemotherapy/Infusion; Dermatology, Soft Tissue Melanoma, Thoracic; Lower Gastrointestinal; Upper Gastrointestinal; Genito-Urology; Head & Neck; Dentistry and Maxillofacial Prosthetics; Pediatric; Gynecology and Hematology/Neurology/Pain. Supporting these centers are clinical resources that include Anesthesiology & Critical Care Medicine; Blood Bank/Plateletpheresis; Clinical Research Services; Community Cancer Resource Center; Diagnostic Imaging; Genetics Counseling/Testing; Infectious Disease Service; Nursing; Pain Medicine; Pathology & Laboratory Medicine; Patient Advocacy; Photodynamic Therapy; Psychosocial Support; RadiationOncology; Rehabilitation (physical, occupational and speech therapy); and Therapeutics (experimental).
Roswell Park Comprehensive Cancer Center also offers specialized treatments, services and therapies including: High-dose Chemotherapy; Photodynamic Therapy; Gamma Knife; Follow-up Clinic for Long- term Survivors of Childhood Cancer; a Regional Center for MaxillofacialProsthetics; Clinical Genetics Testing and Counseling; the Center for HIV-related Malignancies; Lymphedema Clinic; Balloon Kyphoplasty; Brain Mapping; Cancer Pain Management Service; High Risk Breast Clinic; Intraoperative MRI; Minimally Invasive Surgical Suite; Mohs Surgery;
Robotic Surgery and Colorectal Cancer Risk Management Clinic.
3,221 employees, including 308 faculty members and 606 nurses
Average length of service: 9.26 years
Active employees who are members of the 25-Year Club (length of service > 25 years): 365
Hospital admissions: 5,284
Outpatient visits: 205,000
Patients under active care: 31,000
Surgical procedures (annual) 4,200
Patient origin: 48 states, 13 foreign countries
Number of beds: 133 (licensed)
Average length of stay: 7.4 days
Results of patient satisfaction surveys: Over 98 percent of Roswell Park patients consistently rate the care at Roswell Park as excellent or very good and over 97 percent of patients say they would recommend Roswell Park to other cancer patients.
Grant monies (per annum): $92.8 million
Funded research projects: 545
License agreements: 87
U.S. patents: 71
Collaborations with biopharmaceutical companies: 169
New York State Pathological Laboratory of the University of Buffalo, 1898
The Gratwick Research Laboratory, 1900
State Institute for the Study of Malignant Disease, 1911
Roswell Park Memorial Institute (RPMI), 1946
Roswell Park Cancer Institute (RPCI), 1992
Founded in 1898 as the world's first institute devoted exclusively to cancer research
The center's first female leader, Candace S. Johnson, PhD, was named President & CEO in February 2015.
First example of direct government interest (New York State) in cancer research
Pioneered the prostate specific antigen (PSA) test
Pioneered photodynamic therapy (PDT)
Pioneered 5-FU and leucovorin for colorectal cancer - for many years the gold standard chemotherapy for this disease
Leads the nation in the number of robotic cystectomies performed
Established one of the nation's first long-term survivors clinics for childhood cancer patients
Member of international team of scientists who produced the landmark studies of the Human Genome project
Drs. Gerty and Carl Cori jointly won the 1947 Nobel Prize in Physiology or Medicine, "for their discovery of the course of the catalytic conversion of glycogen." Their research leading to the discovery began during their tenure at Roswell Park (then called the New York State Institute for the Study of Malignant Diseases), from 1922-1931.
Thomas Dao (1921-2009), served as director of the breast surgery department from 1957 to 1988, where he developed breast cancer treatment alternatives.